PCC SE consolidates MCAA business into PCC Rokita SA
- PCC SE and PCC Rokita SA signed a letter of intent on 16 June 2026 to transfer MCAA production and marketing into PCC Rokita.
- The planned transaction is a share swap using the weighted six‑month average price of the PCC Rokita share on the Warsaw Stock Exchange.
- A 6‑month VWAP example of 68.05 PLN and an independent PwC valuation imply ~€68m for 100% of the contributed business and issuance of 4,251,619 new shares.
- Integration will centralise MCAA and chlorine operations at the Brzeg Dolny site to pursue process optimisations and synergy effects; completion depends on customary market conditions and corporate approvals.
Transaction plan
PCC SE intends to contribute its subsidiaries MCAA SE and PCC MCAA Sp. z o.o. to PCC Rokita SA, integrating the production and marketing business for monochloroacetic acid (MCAA) into PCC Rokita. The PCC SE and PCC Rokita SA signed a letter of intent to this effect on 16 June 2026. The planned transaction is to be carried out as part of a share swap, with the number of new shares to be issued determined on the transaction date based on the weighted six‑month average price of the PCC Rokita share on the Warsaw Stock Exchange.
Valuation example
Using a six‑month weighted average price example of 68.05 PLN (for a hypothetical transaction on 5 June), an independent valuation prepared by Polish PwC Advisory Sp. z o.o. results in a market value for 100% of the contributed shares of approximately €68 million. Based on this valuation, 4,251,619 new shares of PCC Rokita SA would be issued to PCC SE.
Strategic rationale and conditions
PCC Rokita SA operates the PCC Group’s large Brzeg Dolny production site and produces chlorine, which is the feedstock for MCAA produced and marketed at the same site by PCC MCAA Sp. z o.o. The planned contribution is intended to bundle and centrally control the Chlor & Derivatives core business, enabling further process optimisations and material synergy effects across the Group. The decision to implement the potential transaction depends on various customary market conditions and the necessary corporate approvals from both companies.
Source: PCC SE
